192 related articles for article (PubMed ID: 30144326)
21. Maternal immune activation in late gestation increases neuroinflammation and aggravates experimental autoimmune encephalomyelitis in the offspring.
Zager A; Peron JP; Mennecier G; Rodrigues SC; Aloia TP; Palermo-Neto J
Brain Behav Immun; 2015 Jan; 43():159-71. PubMed ID: 25108214
[TBL] [Abstract][Full Text] [Related]
22. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
[TBL] [Abstract][Full Text] [Related]
23. Physiological functions of the cholinergic system in immune cells.
Fujii T; Mashimo M; Moriwaki Y; Misawa H; Ono S; Horiguchi K; Kawashima K
J Pharmacol Sci; 2017 May; 134(1):1-21. PubMed ID: 28552584
[TBL] [Abstract][Full Text] [Related]
24. Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis.
Bhasin M; Wu M; Tsirka SE
BMC Immunol; 2007 Jul; 8():10. PubMed ID: 17634104
[TBL] [Abstract][Full Text] [Related]
25. A Functionally Defined
Groves A; Kihara Y; Jonnalagadda D; Rivera R; Kennedy G; Mayford M; Chun J
eNeuro; 2018; 5(5):. PubMed ID: 30255127
[TBL] [Abstract][Full Text] [Related]
26. Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis.
Kuo PC; Brown DA; Scofield BA; Paraiso HC; Wang PY; Yu IC; Yen JH
Brain Behav Immun; 2018 May; 70():76-87. PubMed ID: 29604346
[TBL] [Abstract][Full Text] [Related]
27. Potentiating a non-neuronal cardiac cholinergic system reinforces the functional integrity of the blood brain barrier associated with systemic anti-inflammatory responses.
Oikawa S; Kai Y; Mano A; Sugama S; Mizoguchi N; Tsuda M; Muramoto K; Kakinuma Y
Brain Behav Immun; 2019 Oct; 81():122-137. PubMed ID: 31176726
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
[TBL] [Abstract][Full Text] [Related]
29. Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation.
Boghozian R; McKenzie BA; Saito LB; Mehta N; Branton WG; Lu J; Baker GB; Noorbakhsh F; Power C
Glia; 2017 Oct; 65(10):1590-1606. PubMed ID: 28707358
[TBL] [Abstract][Full Text] [Related]
30. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
[TBL] [Abstract][Full Text] [Related]
31. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
32. Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis.
Gerzanich V; Makar TK; Guda PR; Kwon MS; Stokum JA; Woo SK; Ivanova S; Ivanov A; Mehta RI; Morris AB; Bryan J; Bever CT; Simard JM
J Neuroinflammation; 2017 Sep; 14(1):177. PubMed ID: 28865458
[TBL] [Abstract][Full Text] [Related]
33. Distinctive Roles for α7*- and α9*-Nicotinic Acetylcholine Receptors in Inflammatory and Autoimmune Responses in the Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
Liu Q; Whiteaker P; Morley BJ; Shi FD; Lukas RJ
Front Cell Neurosci; 2017; 11():287. PubMed ID: 29018331
[TBL] [Abstract][Full Text] [Related]
34. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.
Moransard M; Bednar M; Frei K; Gassmann M; Ogunshola OO
J Neuroinflammation; 2017 Oct; 14(1):202. PubMed ID: 29029628
[TBL] [Abstract][Full Text] [Related]
35. N-Methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
Bolton C; Wood EG; Ayoub SS
Fundam Clin Pharmacol; 2013 Oct; 27(5):535-43. PubMed ID: 22742874
[TBL] [Abstract][Full Text] [Related]
36. Atf6α deficiency suppresses microglial activation and ameliorates pathology of experimental autoimmune encephalomyelitis.
Ta HM; Le TM; Ishii H; Takarada-Iemata M; Hattori T; Hashida K; Yamamoto Y; Mori K; Takahashi R; Kitao Y; Hori O
J Neurochem; 2016 Dec; 139(6):1124-1137. PubMed ID: 27333444
[TBL] [Abstract][Full Text] [Related]
37. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro.
Carter SL; Müller M; Manders PM; Campbell IL
Glia; 2007 Dec; 55(16):1728-39. PubMed ID: 17902170
[TBL] [Abstract][Full Text] [Related]
38. Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice.
Bing SJ; Ha D; Hwang I; Park E; Ahn G; Song JY; Jee Y
Am J Chin Med; 2016; 44(6):1099-1110. PubMed ID: 27627913
[TBL] [Abstract][Full Text] [Related]
39. Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation.
Pfitzinger PL; Fangmann L; Wang K; Demir E; Gürlevik E; Fleischmann-Mundt B; Brooks J; D'Haese JG; Teller S; Hecker A; Jesinghaus M; Jäger C; Ren L; Istvanffy R; Kühnel F; Friess H; Ceyhan GO; Demir IE
J Exp Clin Cancer Res; 2020 Dec; 39(1):289. PubMed ID: 33357230
[TBL] [Abstract][Full Text] [Related]
40. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).
Musgrave T; Benson C; Wong G; Browne I; Tenorio G; Rauw G; Baker GB; Kerr BJ
Brain Behav Immun; 2011 Nov; 25(8):1677-88. PubMed ID: 21723939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
